Yüklüyor......
Small-Molecule Inhibitors of the MDM2–p53 Protein–Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment: Miniperspective
[Image: see text] Design of small-molecule inhibitors (MDM2 inhibitors) to block the MDM2–p53 protein–protein interaction has been pursued as a new cancer therapeutic strategy. In recent years, potent, selective, and efficacious MDM2 inhibitors have been successfully obtained and seven such compound...
Kaydedildi:
| Yayımlandı: | J Med Chem |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Chemical
Society
2014
|
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4329994/ https://ncbi.nlm.nih.gov/pubmed/25396320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm501092z |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|